Dr Reddy’s Labs

Dr Reddy’s का Q4 मुनाफा 28% घटकर 554 करोड़, निवेशकों को 25 रु/शेयर डिविडेंड देने का एलान

Dr Reddy's Q4 Result: फार्मा कंपनी Dr Reddy's का मुनाफा वित्त वर्ष 2021 की चौथी तिमाही में सालाना आधार पर करी

Dr Reddy's Q4 Result

Dr Reddy’s Q4 profit dips 29 pc to Rs 557 cr

Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20, Dr Reddy's Laboratories said in a regulatory filing.

Dr Reddy’s Laboratories rating – Buy: API supplies for Vascepa are an issue

Gradual ramp-up of drug expected through FY22, with US revenues of $25 m; FY22e EPS down 1%; ‘Buy’ retained with TP of Rs 5,533

डॉ रेड्डीज: इस फार्मा कंपनी ने 6 महीनों में दोगुनी कर दी निवेशकों की दौलत, क्या अभी भी बाकी है दम

Dr Reddy's Stock: फार्मा कंपनी डॉ रेड्डीज का शेयर आज 10 फीसदी तेजी के साथ 5300 रुपये के भाव पर पहुंच गय

Dr Reddy's, Dr Reddy's Stock Rose upto 112% return in last 6 month, Dr Reddy's Stock rose 10% today on 18 september 2020, pharma company, pharma stocks, russian vaccine, should you invest in dr reddy's

Dr Reddy’s Labs Q4 consolidated net profit dips 85% at Rs 74.60 crore

For the financial year ended March 2016, the company reported net profit of Rs 2,001.30 crore, down 9.76 per cent, against Rs 2,217.90 crore in the same quarter last year.

Dr Reddy's Laboratories, Dr Reddy's, Dr Reddy's share price, Dr Reddy's XenoPort, XenoPort, XenoPort Dr Reddy's, business news

Dr Reddy’s Labs shares surge on buyback approval

Dr Reddy's Laboratories shares surged as much as 4 per cent on Wednesday after the pharma company approved buyback of its equity shares up to Rs 1,569 crore.

aurobindo pharma, bse sensex

Dr Reddy’s Laboratories shares hit 52-week low, should you buy?

Dr Reddy's Laboratories hit a fresh 52-week low of Rs 2,953.35 on Wednesday on concerns over Venezuela currency devaluation.

Orient Paper, Sunteck Realty among 67 stocks that hit fresh 52-week high on NSE today

USFDA warns of Dr Reddy’s drug import ban if flaws are not fixed

The USFDA said it had found several violations with regard to current good manufacturing practices (CGMP) at three of Dr Reddy's plants.

Dr Reddy’s Labs shares fall on US law firm’s class-action suit

Dr Reddy's Laboratories share price fell around 7 per cent intraday on Thursday on reports that a US law firm has filed a class-action suit against the drug company.

dr reddy shares
Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Most Read

Advertisement

Top News

Advertisement

Related Articles